梯瓦制药(TEVA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TEVA 梯瓦制药

未开盘 11-21 16:00:00 EST

17.08

+0.05

+0.29%

盘后17.21

+0.13+0.78%

19:52 EST

最高17.17	最低16.90	成交量834.72万
今开17.05	昨收17.03	日振幅1.58%
总市值193.52亿	流通市值192.38亿	总股本11.33亿
成交额1.42亿	换手率0.74%	流通股本11.26亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TEVA","market":"US","secType":"STK","nameCN":"梯瓦制药","latestPrice":17.08,"timestamp":1732222800000,"preClose":17.03,"halted":0,"volume":8347192,"hourTrading":{"tag":"盘后","latestPrice":17.2127,"preClose":17.08,"latestTime":"19:52 EST","volume":2970464,"amount":50735685.7915,"timestamp":1732236752507},"delay":0,"floatShares":1126321708,"shares":1133050214,"eps":-0.856074,"marketStatus":"未开盘","marketStatusCode":0,"change":0.05,"latestTime":"11-21 16:00:00 EST","open":17.05,"high":17.17,"low":16.9012,"amount":142430541.087296,"amplitude":0.015784,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.856074,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732266000000},"adr":0,"adjPreClose":17.03,"adrRate":1,"preHourTrading":{"tag":"盘前","latestPrice":17.04,"preClose":17.03,"latestTime":"09:29 EST","volume":12658,"amount":214953.28267000002,"timestamp":1732199399933},"postHourTrading":{"tag":"盘后","latestPrice":17.2127,"preClose":17.08,"latestTime":"19:52 EST","volume":2970464,"amount":50735685.7915,"timestamp":1732236752507},"volumeRatio":1.008667,"optionData":{"bulkOrders":[{"symbol":"TEVA","call":false,"expireDate":1737090000000,"strike":"17.0","timestamp":1732208307294,"price":1.0299999713897705,"volume":10000,"amount":1030000,"type":"+"},{"symbol":"TEVA","call":false,"expireDate":1737090000000,"strike":"17.0","timestamp":1732205840750,"price":1.0199999809265137,"volume":10000,"amount":1020000,"type":"+"}]},"impliedVol":0.5365,"impliedVolPercentile":0.8056},"requestUrl":"/m/hq/s/TEVA","defaultTab":"news","newsList":[{"id":"2483385742","title":"梯瓦制药2024财年第三财季实现净利润-4.37亿美元，同比减少653.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483385742","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483385742?lang=zh_cn&edition=full","pubTime":"2024-11-15 00:00","pubTimestamp":1731600051,"startTime":"0","endTime":"0","summary":"11月15日，梯瓦制药公布财报，公告显示公司2024财年第三财季净利润为-4.37亿美元，同比减少653.16%；其中营业收入为43.41亿美元，同比增加13.40%，每股基本收益为-0.39美元。从资产负债表来看，梯瓦制药总负债353.74亿美元，其中短期债务25.80亿美元，资产负债比为1.19，流动比率为0.90。机构评级：截至2024年11月15日，当前有7家机构对梯瓦制药目标价做出预测，其中目标均价为23.00美元，其中最低目标价为18.00美元，最高目标价为26.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115000105a237ffda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115000105a237ffda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TEVA"],"gpt_icon":0},{"id":"1178912393","title":"异动解读 | 梯瓦制药盘中重挫8.36% 新政府政策不确定性恐增行业压力","url":"https://stock-news.laohu8.com/highlight/detail?id=1178912393","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178912393?lang=zh_cn&edition=full","pubTime":"2024-11-07 13:09","pubTimestamp":1730956153,"startTime":"0","endTime":"0","summary":"11月6日,梯瓦制药股价盘中重挫逾8%,引发市场广泛关注。公司当季业绩表现强劲,管理层亦对未来增长前景持乐观态度,但投资者担忧特朗普政府未来在医疗保健和制药行业的政策走向存在不确定性,或令制药公司承受更大压力。前期消息显示,梯瓦制药CEO理查德-弗朗西斯先前曾表示,公司预计将与即将上任的特朗普政府开展富有成效的合作,但他承认对特朗普政府的具体政策尚不确定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TEVA"],"gpt_icon":0},{"id":"1145286895","title":"异动解读 | 梯瓦制药股价盘中重挫逾6% 原因有待观察","url":"https://stock-news.laohu8.com/highlight/detail?id=1145286895","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145286895?lang=zh_cn&edition=full","pubTime":"2024-11-06 23:42","pubTimestamp":1730907762,"startTime":"0","endTime":"0","summary":"11月6日,梯瓦制药股价盘中重挫逾6%,引发市场关注。对于股价暴跌的原因,目前尚无明确说法。一些分析人士认为,投资者对特朗普政府的政策前景存在不确定性,或令梯瓦制药遭到不利影响,从而引发资金流出并拖累股价表现。毫无疑问,特朗普政府的政策导向将是影响梯瓦制药后续股价走势的重要因素。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TEVA"],"gpt_icon":0},{"id":"2481984467","title":"梯瓦制药盘中异动 大幅跳水5.01%报17.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481984467","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481984467?lang=zh_cn&edition=full","pubTime":"2024-11-06 23:07","pubTimestamp":1730905639,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日23时07分，梯瓦制药股票出现波动，股价快速下挫5.01%。截至发稿，该股报17.83美元/股，成交量275.219万股，换手率0.24%，振幅7.73%。梯瓦制药股票所在的制药行业中，整体跌幅为1.92%。梯瓦一半的销售额来自北美，占美国仿制药处方总数的高个位数百分比。梯瓦还销售活性药物成分，提供合同生产服务，并拥有总部位于美国的仿制药和专科药物经销商 Anda。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106230719971a4d06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106230719971a4d06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TEVA","BK4585","BK4559","BK4557","BK4584","BK4007","BK4588","BK4596","BK4566"],"gpt_icon":0},{"id":"2481986298","title":"梯瓦制药公司首席执行官表示将与特朗普政府开展富有成效的合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2481986298","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481986298?lang=zh_cn&edition=full","pubTime":"2024-11-06 23:01","pubTimestamp":1730905271,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透耶路撒冷11月6日 - 梯瓦制药工业  首席执行官理查德-弗朗西斯（Richard Francis）周三表示，预计将与即将上任的特朗普政府开展富有成效的合作。\"弗朗西斯在这家以色列制药商发布强劲的第三季度业绩后对路透说：\"我们的工作一如既往，就是与任何政府进行富有成效的合作，我们已经证明了我们能做到这一点，我们也绝对会做到这一点。不过他表示，要等到特朗普上台后才能明确他的医疗保健和制药政策。弗朗西斯还表示，他预计 2025 年公司将 \"一如既往\"，品牌药将增长，仿制药业务将继续增长，生物仿制药的销售也将增加。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","BK4596","BK4585","BK4557","BK4559","BK4584","TEVA","BK4588","BK4007"],"gpt_icon":0},{"id":"2475509056","title":"梯瓦制药盘中异动 下午盘股价大涨5.02%报18.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475509056","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475509056?lang=zh_cn&edition=full","pubTime":"2024-10-16 02:27","pubTimestamp":1729016873,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日02时27分，梯瓦制药股票出现异动，股价大幅拉升5.02%。截至发稿，该股报18.11美元/股，成交量441.204万股，换手率0.39%，振幅4.61%。梯瓦制药股票所在的制药行业中，整体跌幅为0.61%。梯瓦一半的销售额来自北美，占美国仿制药处方总数的高个位数百分比。梯瓦还销售活性药物成分，提供合同生产服务，并拥有总部位于美国的仿制药和专科药物经销商 Anda。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016022754971a071d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016022754971a071d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TEVA","BK4585","BK4559","BK4557","BK4584","BK4007","BK4588","BK4566"],"gpt_icon":0},{"id":"1182104028","title":"减肥药市场要“变天”？诺和诺德与礼来的“平替”竞争对手出现了","url":"https://stock-news.laohu8.com/highlight/detail?id=1182104028","media":"老虎资讯综合","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182104028?lang=zh_cn&edition=full","pubTime":"2024-09-25 17:40","pubTimestamp":1727257205,"startTime":"0","endTime":"0","summary":"梯瓦制药和Sandoz等已推出首批仿制药。","market":"us","thumbnail":"https://static.tigerbbs.com/37608d89603126004448a295afb49463","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/37608d89603126004448a295afb49463"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLY","TEVA","NVO","SDZNY"],"gpt_icon":1},{"id":"2459766106","title":"梯瓦制药盘中异动 早盘急速上涨5.02%报17.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459766106","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459766106?lang=zh_cn&edition=full","pubTime":"2024-08-14 23:20","pubTimestamp":1723648852,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日23时20分，梯瓦制药股票出现波动，股价急速上涨5.02%。截至发稿，该股报17.99美元/股，成交量699.452万股，换手率0.62%，振幅4.85%。梯瓦制药股票所在的制药行业中，整体涨幅为1.76%。梯瓦一半的销售额来自北美，占美国仿制药处方总数的高个位数百分比。梯瓦还销售活性药物成分，提供合同生产服务，并拥有总部位于美国的仿制药和专科药物经销商 Anda。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081423205397198bd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081423205397198bd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","BK4588","BK4007","BK4585","BK4559","BK4566","TEVA","BK4584"],"gpt_icon":0},{"id":"2457753814","title":"梯瓦制药2024财年第二财季实现净利润-8.45亿美元，同比增加1.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457753814","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457753814?lang=zh_cn&edition=full","pubTime":"2024-08-05 00:15","pubTimestamp":1722788131,"startTime":"0","endTime":"0","summary":"8月5日，梯瓦制药公布财报，公告显示公司2024财年第二财季净利润为-8.45亿美元，同比增加1.97%；其中营业收入为41.62亿美元，同比增加7.21%，每股基本收益为-0.75美元。从资产负债表来看，梯瓦制药总负债347.74亿美元，其中短期债务20.94亿美元，资产负债比为1.19，流动比率为0.90。机构评级：截至2024年8月5日，当前有7家机构对梯瓦制药目标价做出预测，其中目标均价为21.29美元，其中最低目标价为16.00美元，最高目标价为24.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805001537957ca9c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805001537957ca9c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TEVA"],"gpt_icon":0},{"id":"2455137474","title":"梯瓦制药(TEVA.US)涨超5.4%报17.3美元。消息面上梯瓦制药第二季度营收41.6亿美元市场预估40.5亿美元；调整后EBITDA为11.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455137474","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455137474?lang=zh_cn&edition=full","pubTime":"2024-07-31 22:11","pubTimestamp":1722435105,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","BK4007","BK4557","BK4585","TEVA","BK4559","BK4584","BK4566"],"gpt_icon":0},{"id":"2455497132","title":"美股异动｜梯瓦制药涨超5.4% Q2营收及全年营收指引均超预期梯瓦制药(TEVA.US)涨超5.4%，报17.3美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455497132","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455497132?lang=zh_cn&edition=full","pubTime":"2024-07-31 22:07","pubTimestamp":1722434859,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["TEVA","BK4585","BK4007","BK4557","BK4588","BK4559","BK4566","BK4584"],"gpt_icon":0},{"id":"2455371551","title":"美股异动｜梯瓦制药涨超5.4% Q2营收及全年营收指引均超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2455371551","media":"港股那点事","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455371551?lang=zh_cn&edition=full","pubTime":"2024-07-31 22:07","pubTimestamp":1722434820,"startTime":"0","endTime":"0","summary":"格隆汇7月31日｜梯瓦制药(TEVA.US)涨超5.4%，报17.3美元。消息面上，梯瓦制药第二季度营收41.6亿美元，市场预估40.5亿美元；调整后EBITDA为11.7亿美元，市场预估11.4亿美元；调整后每股收益0.61美元。该公司预计全年营收160亿至164亿美元，市场预估160.1亿美元；调整后EBITDA为46亿至50亿美元，市场预估47.8亿美元。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/bxjj/2024-07-31/doc-incfzyqs6771967.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2024-07-31/doc-incfzyqs6771967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["TEVA"],"gpt_icon":0},{"id":"1170678524","title":"异动解读 | 梯瓦制药(TEVA)盘中大涨6.67% 二季度业绩超预期引发利好","url":"https://stock-news.laohu8.com/highlight/detail?id=1170678524","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170678524?lang=zh_cn&edition=full","pubTime":"2024-07-31 21:42","pubTimestamp":1722433327,"startTime":"0","endTime":"0","summary":"梯瓦制药今日盘中股价大涨6.67%,报16.7美元,引发市场广泛关注。这主要受到该公司公布的第二季度业绩超预期以及上调全年指引的利好消息所推动。财报数据显示,梯瓦制药第二季度营收为41.6亿美元,高于市场预期的40.5亿美元。值得一提的是,梯瓦制药还上调了全年业绩指引。公司预计全年营收将达到160亿至164亿美元,调整后EBITDA为46亿至50亿美元,调整后每股收益为2.30至2.50美元,均高于此前市场预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEVA"],"gpt_icon":0},{"id":"2455390631","title":"梯瓦制药盘中异动 早盘股价大涨5.06%报17.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455390631","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455390631?lang=zh_cn&edition=full","pubTime":"2024-07-31 21:31","pubTimestamp":1722432673,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日21时31分，梯瓦制药股票出现波动，股价快速拉升5.06%。截至发稿，该股报17.24美元/股，成交量76.7726万股，换手率0.07%，振幅0.61%。梯瓦制药股票所在的制药行业中，整体跌幅为0.06%。梯瓦一半的销售额来自北美，占美国仿制药处方总数的高个位数百分比。梯瓦还销售活性药物成分，提供合同生产服务，并拥有总部位于美国的仿制药和专科药物经销商 Anda。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024073121311396822456&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024073121311396822456&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4007","TEVA","BK4566","BK4557","BK4559","BK4584","BK4588"],"gpt_icon":0},{"id":"1175521884","title":"异动解读 | 梯瓦制药(TEVA)盘前大涨5.24% 二季度业绩超预期引发利好","url":"https://stock-news.laohu8.com/highlight/detail?id=1175521884","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175521884?lang=zh_cn&edition=full","pubTime":"2024-07-31 21:24","pubTimestamp":1722432259,"startTime":"0","endTime":"0","summary":"梯瓦制药今日盘前大涨5.24%,报16.7美元。这主要受到该公司公布的第二季度业绩超预期以及上调全年指引的利好消息所推动。财报数据显示,梯瓦制药第二季度营收为41.6亿美元,高于市场预期的40.5亿美元。调整后EBITDA为11.7亿美元,也超过了分析师预估的11.4亿美元。值得一提的是,梯瓦制药还上调了全年业绩指引。公司预计全年营收将达到160亿至164亿美元,调整后EBITDA为46亿至50亿美元,调整后每股收益为2.30至2.50美元,均高于此前市场预期。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEVA"],"gpt_icon":0},{"id":"2455139068","title":"Teva Pharmaceutical Indus(TEVA.US)：2024年Q2财报实现营收41","url":"https://stock-news.laohu8.com/highlight/detail?id=2455139068","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455139068?lang=zh_cn&edition=full","pubTime":"2024-07-31 20:56","pubTimestamp":1722430596,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Indus(TEVA.US)：2024年Q2财报实现营收41.64亿美元，前值为38.78亿美元，预期值为40.6亿美元；每股收益为0.61美元，前值为0.56美元，预期值为0.55美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407312107349571797b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407312107349571797b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TEVA"],"gpt_icon":0},{"id":"2455874981","title":"梯瓦制药(TEVA)盘前涨超1% 二季度营收41.6亿美元 高于市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2455874981","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455874981?lang=zh_cn&edition=full","pubTime":"2024-07-31 19:50","pubTimestamp":1722426647,"startTime":"0","endTime":"0","summary":"金吾财讯 | 梯瓦制药(TEVA)盘前涨超1%，截止发稿，报16.7美元。消息面上，梯瓦制药第二季度营收41.6亿美元，市场预估40.5亿美元。调整后EBITDA11.7亿美元，市场预估11.4亿美元。调整后每股收益0.61美元。预计全年营收160亿美元至164亿美元，市场预估160.1亿美元。预计全年调整后EBITDA46亿美元至50亿美元，市场预估47.8亿美元。预计全年调整后每股收益2.30美元至2.50美元。","market":"other","thumbnail":"https://static.szfiu.com/news/20210625/OGIwZDQyMDYwMGIwOWQ1NTkxMDE1Mzc1NTA2MDQ=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/OGIwZDQyMDYwMGIwOWQ1NTkxMDE1Mzc1NTA2MDQ=.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"278411","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEVA"],"gpt_icon":0},{"id":"2455189002","title":"梯瓦制药（TEVA）第二季度营收41.6亿美元市场预估40.5亿美元。第二季度调整后EBITDA 11.7亿美元市场预估11.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455189002","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455189002?lang=zh_cn&edition=full","pubTime":"2024-07-31 19:19","pubTimestamp":1722424795,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["TEVA","BK4007","BK4566","BK4557","BK4584","BK4585","BK4588","BK4559"],"gpt_icon":0},{"id":"2455189354","title":"梯瓦制药（TEVA）第二季度营收41.6亿美元，市场预估40.5亿美元。第二季度调整后EBITDA 11.7亿美元，市场预估11.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455189354","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455189354?lang=zh_cn&edition=full","pubTime":"2024-07-31 19:14","pubTimestamp":1722424479,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/us-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/us-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK4588","BK4566","BK4585","BK4584","BK4007","TEVA","BK4559","BK4557"],"gpt_icon":0},{"id":"2450587745","title":"瑞银：维持Teva Pharmaceutical Indus(TEVA.US)评级，由买入调整至买入评级, 目标价由22.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450587745","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450587745?lang=zh_cn&edition=full","pubTime":"2024-07-11 10:11","pubTimestamp":1720663886,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4557","TEVA","BK4007","BK4559","BK4584","BK4588","BK4585","BK4566"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tevapharm.com","stockEarnings":[{"period":"1week","weight":0.0197},{"period":"1month","weight":-0.0707},{"period":"3month","weight":-0.0797},{"period":"6month","weight":0.0289},{"period":"1year","weight":0.8055},{"period":"ytd","weight":0.636}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Teva Pharmaceutical Industries Limited于1944年2月13日在以色列注册成立。该公司是一家全球性制药公司，致力于帮助世界各地的患者获得负担得起的药物，并从改善健康的创新中受益。该公司的使命是成为仿制药、创新药和生物制药领域的全球领导者，改善患者的生活。该公司在全球开展业务，总部设在以色列，并在美国、欧洲和世界各地的许多其他市场都有重要业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.082657},{"month":2,"riseRate":0.416667,"avgChangeRate":-0.0137},{"month":3,"riseRate":0.5,"avgChangeRate":-0.007635},{"month":4,"riseRate":0.25,"avgChangeRate":-0.006929},{"month":5,"riseRate":0.416667,"avgChangeRate":-0.013519},{"month":6,"riseRate":0.538462,"avgChangeRate":0.013933},{"month":7,"riseRate":0.615385,"avgChangeRate":0.035474},{"month":8,"riseRate":0.153846,"avgChangeRate":-0.065595},{"month":9,"riseRate":0.384615,"avgChangeRate":-0.020432},{"month":10,"riseRate":0.384615,"avgChangeRate":-0.021774},{"month":11,"riseRate":0.615385,"avgChangeRate":0.043886},{"month":12,"riseRate":0.5,"avgChangeRate":-0.004471}],"exchange":"NYSE","name":"梯瓦制药","nameEN":"Teva Pharmaceutical"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"梯瓦制药(TEVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供梯瓦制药(TEVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"梯瓦制药,TEVA,梯瓦制药股票,梯瓦制药股票老虎,梯瓦制药股票老虎国际,梯瓦制药行情,梯瓦制药股票行情,梯瓦制药股价,梯瓦制药股市,梯瓦制药股票价格,梯瓦制药股票交易,梯瓦制药股票购买,梯瓦制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"梯瓦制药(TEVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供梯瓦制药(TEVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}